San Francisco Supervisors David Weiner and Scott Campos last week held a hearing to discuss the efforts of a coalition formed to end HIV in a city that was once seen as a center of the epidemic in this country.
Doctors in California believe that they have cleared HIV from the blood of a nine-month-old who seems to have been born with the virus. Though they can’t call it a “cure” or even say she is in remission because she continues to take medication, her doctors believe she has “sero-reverted to HIV-negative.”
PrEP works when used properly. So why don’t women use it?
On January 7, the Microbicide Trials Network (MTN) made the welcome announcement that it had added the first clinical trial of a microbicide for women living with HIV to its research portfolio.
People who participate in clinical trials take the enormous step of volunteering to test a product that may be useful and, sometimes, life-saving if it turns out to be effective. They play an irreplaceable role in research to prevent, treat, and sometimes cure illness – as well as to find other ways to improve people’s health and lives.